Old Web
English
Sign In
Acemap
>
authorDetail
>
Jianzhen Teng
Jianzhen Teng
Nanjing Medical University
Percutaneous coronary intervention
Internal medicine
Medicine
Cardiac fibrosis
Chemistry
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on-treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)-2 Trial.
2021
British Journal of Haematology
Lianghong Ying
Jing Wang
Juan Li
Jianzhen Teng
Xiaofeng Zhang
Inam Ullah
Abdus Samee
Ke Xu
Jun Chen
Lei Xu
Hui Zhu
Jimin Li
Lu Yang
Fei Wang
Yuansheng Fan
Jing Zhang
Yi Lu
Xiaoxuan Gong
Lu Shi
John W. Eikelboom
Chunjian Li
Show All
Source
Cite
Save
Citations (0)
An Optimal Window of Platelet Reactivity by LTA Assay for Patients Undergoing Percutaneous Coronary Intervention
2021
Jing Wang
Jiazheng Ma
Jianzhen Teng
Xiaofeng Zhang
Qian. Gu
Zekang Ye
Inam Ullah
Chuchu Tan
Samee Abdus
Lu Shi
Xiaoxuan Gong
Chunjian Li
Show All
Source
Cite
Save
Citations (0)
MicroRNA‑133b alleviates doxorubicin‑induced cardiomyocyte apoptosis and cardiac fibrosis by targeting PTBP1 and TAGLN2.
2021
International Journal of Molecular Medicine
Zhen Li
Zekang Ye
Jiazheng Ma
Qian Gu
Jianzhen Teng
Xiaoxuan Gong
Show All
Source
Cite
Save
Citations (2)
1